412 related articles for article (PubMed ID: 19744432)
21. [Prognostic factors influencing results of the surgical treatment of pancreatic cancer].
Ignashov AM; Kokhanenko NIu; Lisochkin BG; Savrasov VM; Volkov ON; Dvorakovskaia IV; Lebedev EG; Kulikov IuV
Vestn Khir Im I I Grek; 2001; 160(1):33-6. PubMed ID: 11258321
[TBL] [Abstract][Full Text] [Related]
22. The impact of obesity on outcomes following pancreatectomy for malignancy.
Benns M; Woodall C; Scoggins C; McMasters K; Martin R
Ann Surg Oncol; 2009 Sep; 16(9):2565-9. PubMed ID: 19557479
[TBL] [Abstract][Full Text] [Related]
23. [The surgical possibilities in patients with adenocarcinoma of the pancreas].
de la Garza L
Rev Gastroenterol Mex; 1995; 60(2):84-93. PubMed ID: 7543695
[TBL] [Abstract][Full Text] [Related]
24. Cancer of the exocrine pancreas. A plea for resection.
Huguier M; Baumel H; Manderscheid JC
Hepatogastroenterology; 1996; 43(9):721-9. PubMed ID: 8799420
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors after distal pancreatectomy with extended lymphadenectomy for invasive pancreatic adenocarcinoma of the body and tail.
Shimada K; Sakamoto Y; Sano T; Kosuge T
Surgery; 2006 Mar; 139(3):288-95. PubMed ID: 16546491
[TBL] [Abstract][Full Text] [Related]
26. Pancreatic resection of isolated metastases from nonpancreatic primary cancers.
Reddy S; Edil BH; Cameron JL; Pawlik TM; Herman JM; Gilson MM; Campbell KA; Schulick RD; Ahuja N; Wolfgang CL
Ann Surg Oncol; 2008 Nov; 15(11):3199-206. PubMed ID: 18784960
[TBL] [Abstract][Full Text] [Related]
27. Microscopically incomplete resection offers acceptable palliation in pancreatic cancer.
Kuhlmann K; de Castro S; van Heek T; Busch O; van Gulik T; Obertop H; Gouma D
Surgery; 2006 Feb; 139(2):188-96. PubMed ID: 16455327
[TBL] [Abstract][Full Text] [Related]
28. Increased preoperative platelet count is associated with decreased survival after resection for adenocarcinoma of the pancreas.
Brown KM; Domin C; Aranha GV; Yong S; Shoup M
Am J Surg; 2005 Mar; 189(3):278-82. PubMed ID: 15792750
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic resection for metastatic tumors to the pancreas.
Sperti C; Pasquali C; Liessi G; Pinciroli L; Decet G; Pedrazzoli S
J Surg Oncol; 2003 Jul; 83(3):161-6; discussion 166. PubMed ID: 12827684
[TBL] [Abstract][Full Text] [Related]
30. The incidence and outcomes of pancreatectomy in patients with metastatic pancreatic adenocarcinoma.
McKenzie S; Mailey B; Artinyan A; Kim J; Ellenhorn JD
JOP; 2010 Jul; 11(4):341-7. PubMed ID: 20601808
[TBL] [Abstract][Full Text] [Related]
31. Critical appraisal of 232 consecutive distal pancreatectomies with emphasis on risk factors, outcome, and management of the postoperative pancreatic fistula: a 21-year experience at a single institution.
Goh BK; Tan YM; Chung YF; Cheow PC; Ong HS; Chan WH; Chow PK; Soo KC; Wong WK; Ooi LL
Arch Surg; 2008 Oct; 143(10):956-65. PubMed ID: 18936374
[TBL] [Abstract][Full Text] [Related]
32. Pancreatectomy for adenocarcinoma in elderly patients: postoperative outcomes and long term results: a study of the French Surgical Association.
Turrini O; Paye F; Bachellier P; Sauvanet A; Sa Cunha A; Le Treut YP; Adham M; Mabrut JY; Chiche L; Delpero JR;
Eur J Surg Oncol; 2013 Feb; 39(2):171-8. PubMed ID: 22999411
[TBL] [Abstract][Full Text] [Related]
33. Preoperative serum CA19-9 and dissected peripancreatic tissue margin as determiners of long-term survival in pancreatic cancer.
Waraya M; Yamashita K; Katagiri H; Ishii K; Takahashi Y; Furuta K; Watanabe M
Ann Surg Oncol; 2009 May; 16(5):1231-40. PubMed ID: 19263172
[TBL] [Abstract][Full Text] [Related]
34. Review of adjuvant radiochemotherapy for resected pancreatic cancer and results from Mayo Clinic for the 5th JUCTS symposium.
Miller RC; Iott MJ; Corsini MM
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):364-8. PubMed ID: 19735864
[TBL] [Abstract][Full Text] [Related]
35. Resectional surgical procedures for carcinoma of the head of the pancreas.
Lygidakis NJ; van der Hyde MN; Houthoff HJ; Schipper ME; Huibregtse K; Tytgat GN; Lubber MJ; Reeders JW; Bosey MM; Oosting J
Surg Gynecol Obstet; 1989 Feb; 168(2):157-65. PubMed ID: 2911793
[TBL] [Abstract][Full Text] [Related]
36. Is celiac axis resection justified for T4 pancreatic body cancer?
Yamamoto Y; Sakamoto Y; Ban D; Shimada K; Esaki M; Nara S; Kosuge T
Surgery; 2012 Jan; 151(1):61-9. PubMed ID: 22088810
[TBL] [Abstract][Full Text] [Related]
37. Peri-operative mortality and long-term survival after total pancreatectomy for pancreatic adenocarcinoma: a population-based perspective.
Nathan H; Wolfgang CL; Edil BH; Choti MA; Herman JM; Schulick RD; Cameron JL; Pawlik TM
J Surg Oncol; 2009 Feb; 99(2):87-92. PubMed ID: 19021191
[TBL] [Abstract][Full Text] [Related]
38. The impact of lymph node number on survival in patients with lymph node-negative pancreatic cancer.
Hellan M; Sun CL; Artinyan A; Mojica-Manosa P; Bhatia S; Ellenhorn JD; Kim J
Pancreas; 2008 Jul; 37(1):19-24. PubMed ID: 18580439
[TBL] [Abstract][Full Text] [Related]
39. Distal pancreatectomy combined with celiac axis resection in treatment of carcinoma of the body/tail of the pancreas: a single-center experience.
Wu X; Tao R; Lei R; Han B; Cheng D; Shen B; Peng C
Ann Surg Oncol; 2010 May; 17(5):1359-66. PubMed ID: 20198445
[TBL] [Abstract][Full Text] [Related]
40. 672 patients with acinar cell carcinoma of the pancreas: a population-based comparison to pancreatic adenocarcinoma.
Wisnoski NC; Townsend CM; Nealon WH; Freeman JL; Riall TS
Surgery; 2008 Aug; 144(2):141-8. PubMed ID: 18656619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
